Status:
UNKNOWN
Lymphocytic Herpesviruses and Cerebrospinal Fluid Polymerase Chain Reaction (PCR)
Lead Sponsor:
PaijatHame Central Hospital
Collaborating Sponsors:
University of Turku
Conditions:
Central Nervous System Infection
Eligibility:
All Genders
16-80 years
Brief Summary
Enterovirus and herpes simplex viruses 1 and 2 are the main causative agents of central nervous system infections. Instead, the role of lymphocytic herpesviruses in the etiology of central nervous sy...
Eligibility Criteria
Inclusion
- Immunocompetent patients with clinical symptoms and signs of central nervous system infections and CSF pleocytosis (pleocytosis group)
- Immunocompetent patients without suspicion of CNS infection and no CSF pleocytosis (non-pleocytosis group)
Exclusion
- Suspicion of CNS-infection, eg. encephalitis, but no CSF leukocytosis (pleocytosis group)
- Patients without symptoms of CNS infection, but who has CSF pleocytosis of unknown origin (non-pleocytosis group)
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01438879
Start Date
October 1 2011
End Date
December 1 2013
Last Update
September 22 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PaijatHame Central Hospital
Lahti, Finland, 15850